Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Ratios and Metrics

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2024 Q3 2023 Q1 2023 Q3 2022 Q1 2022 Q3 2021 Q1 2021
Period Ending Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
PE Ratio
-1.38 9.52 -0.43 0.33 0.05 0.03 1.47
PEG Ratio
n/a n/a n/a n/a n/a n/a 0.00
PS Ratio
2.09 4.59 2.30 0.53 0.08 0.06 1.95
PB Ratio
0.07 0.07 0.07 0.07 0.07 0.11 0.86
P/FCF Ratio
6.91 -4.85 362.08 -0.59 0.11 0.07 1.51
P/OCF Ratio
4.41 -16.11 4.24 -0.8 0.10 0.07 1.33
OCF/S Ratio
0.47 -0.28 0.54 -0.67 0.75 0.83 1.47
Debt / Equity Ratio
0.03 0.03 0.01 0.01 0.02 0.03 0.18
Quick Ratio
10.18 9.74 10.94 22.75 6.03 3.41 2.14
Current Ratio
10.31 9.89 11.11 23.22 6.18 3.53 2.30
Asset Turnover
0.02 0.01 0.02 0.08 0.50 0.87 0.17
Interest Coverage
-61.65 -1.63K -1.68K 990.12 5.65K 6.66K 600.37
Return on Equity
-0.01 n/a -0.04 0.05 0.36 0.87 0.15
Return on Assets
-0.01 n/a -0.03 0.03 0.20 0.40 0.06
Return on Invested Capital
-0.02 -0.02 -0.06 0.04 0.41 0.91 0.14
Dividend Yield
n/a n/a n/a n/a 2.92 n/a n/a
Payout Ratio
n/a n/a n/a n/a 0.56 n/a n/a
Gross Profit Margin
1.00 -0.34 -0.53 0.79 0.95 0.94 0.87
Net Profit Margin
-0.38 0.12 -1.32 0.40 0.40 0.47 0.33
Pretax Profit Margin
-0.29 -0.45 -3.21 0.76 0.88 0.93 0.61
Operating Profit Margin
-0.4 -3.07 -3.85 0.51 0.88 0.92 0.60
FCF Margin
n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin
-0.2 -2.47 -3.56 0.57 0.89 0.92 0.61